Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (81)
  • 2024 (54)
  • 2023 (102)
  • 2022 (169)
  • 2021 (148)
  • 2020 (32)
  • 2019 (20)
  • 2018 (6)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (1116)
  • Synthetic drugs (374)
  • Guns/Weapons (285)
  • OCDETF/Task Force (196)
  • Seizures (Drugs/Property) (176)
  • Guilty Plea (160)
  • Fake Pills (112)
  • Arrests/Convictions - Major (108)
  • Task Forces/Task Force Officers (105)
  • Overdose (100)
  • Pharmaceuticals/Pharmacists/Physicians (65)
  • Diversion Division (54)
  • Outreach/Drug Prevention (48)
  • Gangs (46)
  • Money Laundering (40)
  • Take Back Day (39)
  • HIDTA (30)
  • Press Conferences (25)
  • Public and Media Affairs - also see Congressional Affairs (24)
  • Prevention/Education - DEA websites GSAD, JTT etc (18)
  • Narcoterrorism (16)
  • Extraditions (11)
  • Dark Web- Internet Trafficking (7)
  • International/Foreign Operations (7)
  • Asset Forfeiture (6)
  • Fentanyl Awareness (6)
  • One Pill Can Kill (4)
  • Intergovernmental Affairs (3)
  • Museum and Visitors Center (3)
  • Red Ribbon (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Terrorism (1)
  • Major Law Enforcement Operation (91)
  • Prescription Drugs (84)

Drug Name

  • Fentanyl (45)
  • Cocaine (33)
  • Heroin (26)
  • Methamphetamine (25)
  • Oxycodone (19)
  • Opioids (18)
  • Synthetic Opioids (12)
  • Hydromorphone (10)
  • Marijuana (Cannabis) (5)
  • Benzodiazepines (4)
  • Amphetamines (3)
  • Methadone (2)
  • Morphine (2)
  • Steroids (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Ecstasy/MDMA (1)
  • K2/Spice (1)

Field Division

  • Washington, DC (73)
  • New York (11)
  • St. Louis (11)
  • El Paso (9)
  • New Jersey (9)
  • Miami (7)
  • Seattle (7)
  • Dallas (6)
  • Houston (6)
  • Atlanta (5)
  • New England (5)
  • Chicago (4)
  • San Diego (4)
  • San Francisco (3)
  • Sede (3)
  • Phoenix (2)
  • Rocky Mountain (2)
  • New Orleans (1)
  • Omaha (1)
Clear All Results
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

Diciembre 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
Diciembre 29, 2022
PRESS RELEASE

Flight Attendant Pleads Guilty to Possessing Fentanyl with the Intent to Distribute

Diciembre 27, 2022
SAN DIEGO - Terese L. White, a flight attendant residing in Dallas, Texas, has pleaded guilty in federal court to a drug-trafficking charge, admitting that she used her privileges as a flight attendant to bypass the more robust security screening process at San Diego International Airport in order to smuggle...
Diciembre 27, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

Butte Drug Trafficking Organization with Ties to the Sinaloa Cartel Dismantled

Diciembre 16, 2022
BUTTE, Mont. — A multi-agency investigation into a drug trafficking organization with ties to the Sinaloa Cartel, which brought massive quantities of methamphetamine, counterfeit oxycodone pills containing fentanyl and heroin to Butte for redistribution, has resulted in the federal convictions of 22 people. U.S. Attorney Jesse Laslovich hosted a press...
Diciembre 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

Diciembre 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
Diciembre 15, 2022
PRESS RELEASE

Kansas Pharmacy Agrees to Pay $3 Million for Improperly Dispensing Meds

Diciembre 13, 2022
KANSAS CITY, Kan. - PharmScript of KS, LLC, a long-term care pharmacy in Lenexa, Kansas, has agreed to pay $3 million to resolve allegations that it violated federal law by dispensing controlled substances to residents in nursing and long-term care facilities without valid prescriptions and that the company was wrongfully...
Diciembre 13, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

Diciembre 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
Diciembre 09, 2022
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
PRESS RELEASE

South Georgia Physician Sentenced to Prison after Admitting Conspiracy to Illegally Distribute Drugs

Noviembre 28, 2022
SAVANNAH, GA - A Coffee County, Ga., physician has been sentenced to five years in federal prison after he admitted to participating in a drug trafficking conspiracy that distributed massive amounts of addictive-controlled substances from pain management and addiction clinics. Dr. Wallace Steven Anderson, 68, of Douglas, Ga., was sentenced...
Noviembre 28, 2022
PRESS RELEASE

DEA Washington Division Hosts 1st Family Summit to Engage with Families Affected by Fentanyl Poisoning

Noviembre 22, 2022
WASHINGTON, DC – The Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural Family...
Noviembre 22, 2022
Showing 1 - 10 of 169 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster